Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.

MLA

Wilding, J. P. H., et al. “Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Sulphonylurea: A Randomised Trial.” International Journal of Clinical Practice, vol. 67, no. 12, Dec. 2013, pp. 1267–82. EBSCOhost, https://doi.org/10.1111/ijcp.12322.

APA

Wilding, J. P. H., Charpentier, G., Hollander, P., González-Gálvez, G., Mathieu, C., Vercruysse, F., Usiskin, K., Law, G., Black, S., Canovatchel, W., & Meininger, G. (2013). Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial. International Journal of Clinical Practice, 67(12), 1267–1282. https://doi.org/10.1111/ijcp.12322

Chicago

Wilding, J P H, G Charpentier, P Hollander, G González-Gálvez, C Mathieu, F Vercruysse, K Usiskin, et al. 2013. “Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Sulphonylurea: A Randomised Trial.” International Journal of Clinical Practice 67 (12): 1267–82. doi:10.1111/ijcp.12322.